Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP7018693B2 - 2-O-α-D-maltosyl-L-ascorbic acid-containing composition and method for producing the same - Google Patents
[go: Go Back, main page]

JP7018693B2 - 2-O-α-D-maltosyl-L-ascorbic acid-containing composition and method for producing the same - Google Patents

2-O-α-D-maltosyl-L-ascorbic acid-containing composition and method for producing the same Download PDF

Info

Publication number
JP7018693B2
JP7018693B2 JP2018554258A JP2018554258A JP7018693B2 JP 7018693 B2 JP7018693 B2 JP 7018693B2 JP 2018554258 A JP2018554258 A JP 2018554258A JP 2018554258 A JP2018554258 A JP 2018554258A JP 7018693 B2 JP7018693 B2 JP 7018693B2
Authority
JP
Japan
Prior art keywords
ascorbic acid
glycosyl
maltosyl
composition
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018554258A
Other languages
Japanese (ja)
Other versions
JPWO2018101431A1 (en
Inventor
晃典 梅山
正明 田村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Carlit Co Ltd
Original Assignee
Carlit Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlit Co Ltd filed Critical Carlit Co Ltd
Publication of JPWO2018101431A1 publication Critical patent/JPWO2018101431A1/en
Application granted granted Critical
Publication of JP7018693B2 publication Critical patent/JP7018693B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/18Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/22Preparation of compounds containing saccharide radicals produced by the action of a beta-amylase, e.g. maltose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Description

本発明は、保湿性及び肌の濡れ性に優れた2-O-α-D-マルトシル-L-アスコルビン酸含有組成物とその製造方法に関する。 The present invention relates to a 2-O-α-D-maltosyl-L-ascorbic acid-containing composition having excellent moisturizing properties and skin wettability, and a method for producing the same.

2-O-α-D-グリコシル-L-アスコルビン酸は、下記一般式(1) 2-O-α-D-glycosyl-L-ascorbic acid has the following general formula (1).

Figure 0007018693000001
Figure 0007018693000001

(式中、nは1以上の整数を示す。)
で示される化学構造を有し、加水分解によりL-アスコルビン酸と糖化合物に分解する。2-O-α-D-グリコシル-L-アスコルビン酸はL-アスコルビン酸よりも酸化されにくく安定性に優れる一方で、体内では容易に加水分解されL-アスコルビン酸と同等の生理活性を有することが知られており(特許文献1及び2)、化粧品、食品及び医薬品など、広い応用が期待される。
(In the formula, n indicates an integer of 1 or more.)
It has a chemical structure shown by and is decomposed into L-ascorbic acid and a sugar compound by hydrolysis. 2-O-α-D-glycosyl-L-ascorbic acid is less likely to be oxidized than L-ascorbic acid and has excellent stability, but it is easily hydrolyzed in the body and has the same physiological activity as L-ascorbic acid. Is known (Patent Documents 1 and 2), and is expected to have a wide range of applications such as cosmetics, foods and pharmaceuticals.

2-O-α-D-グリコシル-L-アスコルビン酸は、L-アスコルビン酸とデキストリンとの混合物に糖転移酵素を作用させることにより、上記一般式(1)のnが1~7程度の化合物の混合物として得ることができる。しかし、当該混合物はべたつきが強いなど、応用材料として好ましくない性質を備えているため、当該混合物にグルコアミラーゼを作用させ、精製した結果の、n=1である2-O-α-D-グルコピラノシル-L-アスコルビン酸のみが用いられてきた(特許文献1)。一方で、2-O-α-D-グルコピラノシル-L-アスコルビン酸は、保湿性や肌の濡れ性が不十分であり、化粧品などの皮膚外用剤としてより有用な化合物が求められていた。 2-O-α-D-glycosyl-L-ascorbic acid is a compound having n of about 1 to 7 in the above general formula (1) by allowing a glycosyltransferase to act on a mixture of L-ascorbic acid and dextrin. Can be obtained as a mixture of. However, since the mixture has unfavorable properties as an applied material such as strong stickiness, 2-O-α-D-glucopyranosyl having n = 1 as a result of allowing glucoamylase to act on the mixture and purifying the mixture. Only -L-ascorbic acid has been used (Patent Document 1). On the other hand, 2-O-α-D-glucopyranosyl-L-ascorbic acid is insufficient in moisturizing property and wettability of the skin, and a compound more useful as a skin external preparation such as cosmetics has been sought.

特開平03-135992号公報Japanese Unexamined Patent Publication No. 03-135992 特開平03-183492号公報Japanese Unexamined Patent Publication No. 03-183492

2-O-α-D-マルトシル-L-アスコルビン酸を含有してなる、べたつきがなく、保湿性及び肌の濡れ性に優れた組成物を提供することを課題とする。 It is an object of the present invention to provide a composition containing 2-O-α-D-maltosyl-L-ascorbic acid, which is non-greasy and has excellent moisturizing property and skin wettability.

本発明者らは、鋭意研究の結果、下記一般式(1)で表される2-O-α-D-グリコシル-L-アスコルビン酸のうち、 As a result of diligent research, the present inventors among 2-O-α-D-glycosyl-L-ascorbic acid represented by the following general formula (1).

Figure 0007018693000002
Figure 0007018693000002

(式中、nは1以上の整数を示す。)
これまで有用とは思われていなかったn=2である2-O-α-D-マルトシル-L-アスコルビン酸が特に保湿性及び肌の濡れ性に優れることを見出し、本発明を完成させた。すなわち本発明は以下に示すとおりである。
(In the formula, n indicates an integer of 1 or more.)
We have found that 2-O-α-D-martosyl-L-ascorbic acid, which has not been considered to be useful until now, is particularly excellent in moisturizing property and skin wettability, and completed the present invention. .. That is, the present invention is as shown below.

(1)下記一般式(1) (1) The following general formula (1)

Figure 0007018693000003
Figure 0007018693000003

(式中、nは1以上の整数を示す。)
で表わされる2-O-α-D-グリコシル-L-アスコルビン酸又はその塩を含有する組成物であって、前記2-O-α-D-グリコシル-L-アスコルビン酸中の70モル%以上が2-O-α-D-マルトシル-L-アスコルビン酸(n=2)であることを特徴とする、2-O-α-D-マルトシル-L-アスコルビン酸含有組成物。
(2)
前記2-O-α-D-グリコシル-L-アスコルビン酸中の90モル%以上が2-O-α-D-マルトシル-L-アスコルビン酸(n=2)であることを特徴とする、(1)に記載の2-O-α-D-マルトシル-L-アスコルビン酸含有組成物。
(3)
前記2-O-α-D-グリコシル-L-アスコルビン酸中の、n=4以上の2-O-α-D-グリコシル-L-アスコルビン酸の割合が1モル%以下であることを特徴とする、(1)又は(2)に記載の2-O-α-D-マルトシル-L-アスコルビン酸含有組成物。
(4)
粉末であることを特徴とする(1)から(3)のいずれか一項に記載の2-O-α-D-マルトシル-L-アスコルビン酸含有組成物。
(5)
(1)から(4)のいずれか一項に記載の2-O-α-D-マルトシル-L-アスコルビン酸含有組成物を含有することを特徴とする皮膚外用剤。
(6)
2-O-α-D-マルトシル-L-アスコルビン酸又はその塩。
(7)
(a)下記一般式(1)
(In the formula, n indicates an integer of 1 or more.)
A composition containing 2-O-α-D-glycosyl-L-ascorbic acid or a salt thereof, which is represented by 70 mol% or more of the 2-O-α-D-glycosyl-L-ascorbic acid. 2-O-α-D-maltosyl-L-ascorbic acid-containing composition, characterized in that is 2-O-α-D-maltosyl-L-ascorbic acid (n = 2).
(2)
90 mol% or more of the 2-O-α-D-glycosyl-L-ascorbic acid is 2-O-α-D-maltosyl-L-ascorbic acid (n = 2). The 2-O-α-D-maltosyl-L-ascorbic acid-containing composition according to 1).
(3)
The proportion of 2-O-α-D-glycosyl-L-ascorbic acid having n = 4 or more in the 2-O-α-D-glycosyl-L-ascorbic acid is 1 mol% or less. 2. The 2-O-α-D-maltosyl-L-ascorbic acid-containing composition according to (1) or (2).
(4)
The 2-O-α-D-maltosyl-L-ascorbic acid-containing composition according to any one of (1) to (3), which is a powder.
(5)
An external skin preparation containing the 2-O-α-D-maltosyl-L-ascorbic acid-containing composition according to any one of (1) to (4).
(6)
2-O-α-D-maltosyl-L-ascorbic acid or a salt thereof.
(7)
(A) The following general formula (1)

Figure 0007018693000004
Figure 0007018693000004

(式中、nは1以上の整数を示す。)
で表わされる2-O-α-D-グリコシル-L-アスコルビン酸であって、n=1~7の2-O-α-D-グリコシル-L-アスコルビン酸を全て含む混合物を用意する工程と、
(b)前記混合物にβ-アミラーゼを作用させる工程と、
(c)β-アミラーゼを作用させた前記混合物を精製して2-O-α-D-マルトシル-L-アスコルビン酸含有組成物を得る工程
を有することを特徴とする、2-O-α-D-マルトシル-L-アスコルビン酸含有組成物の製造方法。
(In the formula, n indicates an integer of 1 or more.)
A step of preparing a mixture of 2-O-α-D-glycosyl-L-ascorbic acid represented by 2 and containing all of 2-O-α-D-glycosyl-L-ascorbic acid having n = 1 to 7. ,
(B) A step of allowing β-amylase to act on the mixture, and
(C) 2-O-α-, which comprises a step of purifying the mixture on which β-amylase is allowed to act to obtain a 2-O-α-D-maltosyl-L-ascorbic acid-containing composition. A method for producing a D-maltosyl-L-ascorbic acid-containing composition.

本発明によれば、保湿性及び肌の濡れ性に優れ、化粧品など皮膚外用剤として有用な2-O-α-D-マルトシル-L-アスコルビン酸含有組成物を提供することができる。 According to the present invention, it is possible to provide a 2-O-α-D-maltosyl-L-ascorbic acid-containing composition which is excellent in moisturizing property and wettability of the skin and is useful as a skin external preparation such as cosmetics.

<2-O-α-D-グリコシル-L-アスコルビン酸>
本明細書において、2-O-α-D-グリコシル-L-アスコルビン酸とは下記一般式(1):
<2-O-α-D-glycosyl-L-ascorbic acid>
In the present specification, 2-O-α-D-glycosyl-L-ascorbic acid is the following general formula (1):

Figure 0007018693000005
Figure 0007018693000005

(式中、nは1以上の整数を示す。)
で表される2-O-α-D-グリコシル-L-アスコルビン酸の1種又はそれらの混合物である。前記一般式(1)のnは、L-アスコルビン酸の2位に結合しているグルコース残基のα位に結合する糖(グルコース)の数を意味する1以上の整数である。本発明の2-O-α-D-グリコシル-L-アスコルビン酸は、2-O-α-D-グルコピラノシル-L-アスコルビン酸(n=1)、2-O-α-D-マルトシル-L-アスコルビン酸(n=2)、2-O-α-D-マルトトリオシル-L-アスコルビン酸(n=3)、2-O-α-D-マルトテトラオシル-L-アスコルビン酸(n=4)、2-O-α-D-マルトペンタオシル-L-アスコルビン酸(n=5)、2-O-α-D-マルトヘキサオシル-L-アスコルビン酸(n=6)、2-O-α-D-マルトヘプタオシル-L-アスコルビン酸(n=7)、又は2-O-α-D-マルトオクタオシル-L-アスコルビン酸(n=8)のいずれか又はそれらの混合物であってよい。
(In the formula, n indicates an integer of 1 or more.)
It is one kind of 2-O-α-D-glycosyl-L-ascorbic acid represented by or a mixture thereof. N in the general formula (1) is an integer of 1 or more meaning the number of sugars (glucose) bound to the α-position of the glucose residue bound to the 2-position of L-ascorbic acid. The 2-O-α-D-glycosyl-L-ascorbic acid of the present invention is 2-O-α-D-glucopyranocil-L-ascorbic acid (n = 1), 2-O-α-D-maltosyl-L. -Ascorbic acid (n = 2), 2-O-α-D-maltotriosyl-L-ascorbic acid (n = 3), 2-O-α-D-maltotetraosyl-L-ascorbic acid (n) = 4), 2-O-α-D-maltopentaosyl-L-ascorbic acid (n = 5), 2-O-α-D-maltohexaosyl-L-ascorbic acid (n = 6), Either 2-O-α-D-maltoheptaosyl-L-ascorbic acid (n = 7) or 2-O-α-D-maltooctaosyl-L-ascorbic acid (n = 8) or It may be a mixture thereof.

本発明の2-O-α-D-マルトシル-L-アスコルビン酸含有組成物は、2-O-α-D-マルトシル-L-アスコルビン酸又はその塩を含有する組成物を意味する。本発明の2-O-α-D-マルトシル-L-アスコルビン酸含有組成物は、保湿性、べたつき、肌への濡れ性の観点から、その組成中の2-O-α-D-グリコシル-L-アスコルビン酸のうち、50モル%以上、60モル%以上、70モル%以上、80モル%以上、90モル%以上、95モル%以上が2-O-α-D-マルトシル-L-アスコルビン酸であることが好ましい。2-O-α-D-マルトシル-L-アスコルビン酸含有組成物以外の2-O-α-D-グリコシル-L-アスコルビン酸は、2-O-α-D-グルコピラノシル-L-アスコルビン酸(n=1)、及び/又は2-O-α-D-マルトトリオシル-L-アスコルビン酸(n=3)であることが好ましい。n=4以上の2-O-α-D-グリコシル-L-アスコルビン酸は10モル%以下、5モル%以下、1モル%以下、0.1モル%以下であることが好ましく、実質的に含まないことが好ましい。 The 2-O-α-D-maltosyl-L-ascorbic acid-containing composition of the present invention means a composition containing 2-O-α-D-maltosyl-L-ascorbic acid or a salt thereof. The 2-O-α-D-maltosyl-L-ascorbic acid-containing composition of the present invention has 2-O-α-D-glycosyl-glycosyl in the composition from the viewpoint of moisturizing property, stickiness and wettability to the skin. Of L-ascorbic acid, 50 mol% or more, 60 mol% or more, 70 mol% or more, 80 mol% or more, 90 mol% or more, 95 mol% or more are 2-O-α-D-maltosyl-L-ascorbic. It is preferably an acid. 2-O-α-D-glycosyl-L-ascorbic acid other than the composition containing 2-O-α-D-maltosyl-L-ascorbic acid is a 2-O-α-D-glucopyranocil-L-ascorbic acid ( n = 1) and / or 2-O-α-D-maltotriosyl-L-ascorbic acid (n = 3) are preferred. 2-O-α-D-glycosyl-L-ascorbic acid having n = 4 or more is preferably 10 mol% or less, 5 mol% or less, 1 mol% or less, 0.1 mol% or less, and is substantially. It is preferable not to include it.

2-O-α-D-グリコシル-L-アスコルビン酸は公知の方法、例えば特許文献1に記載の方法により製造することができる。
2-O-α-D-マルトシル-L-アスコルビン酸含有組成物を含有し、かつn=4以上の2-O-α-D-グリコシル-L-アスコルビン酸を実質的に含有しない組成物は、2-O-α-D-グリコシル-L-アスコルビン酸混合物にβ-アミラーゼを作用させることで得ることができる。
本発明の2-O-α-D-マルトシル-L-アスコルビン酸含有組成物は例えば以下のような工程によって得ることができる。
(1)L-アスコルビン酸とα-グルコピラノシル糖化合物とを含有する溶液に、糖転移酵素を作用させ、2-O-α-D-グリコシル-L-アスコルビン酸(n=1~7)の混合溶液を得、次いで当該混合溶液にβ-アミラーゼを作用させることによってn=4以上となる糖鎖を切断し、2-O-α-D-グリコシル-L-アスコルビン酸(n=1~3)含有溶液を作製する。
(2)当該2-O-α-D-グリコシル-L-アスコルビン酸(n=1~3)含有溶液を、イオン交換樹脂等を用いて、未反応のL-アスコルビン酸と糖類を除去し精製する。
(3)溶媒を除去して粉末の2-O-α-D-グリコシル-L-アスコルビン酸(n=1~3)を得る。
工程(2)の生成時の条件によって2-O-α-D-マルトシル-L-アスコルビン酸の含有比率を制御することができる。
2-O-α-D-glycosyl-L-ascorbic acid can be produced by a known method, for example, the method described in Patent Document 1.
A composition containing 2-O-α-D-maltosyl-L-ascorbic acid and substantially free of 2-O-α-D-glycosyl-L-ascorbic acid having n = 4 or more. , 2-O-α-D-glycosyl-L-ascorbic acid mixture can be obtained by reacting β-amylase.
The 2-O-α-D-maltosyl-L-ascorbic acid-containing composition of the present invention can be obtained, for example, by the following steps.
(1) Glycosyltransferase is allowed to act on a solution containing L-ascorbic acid and an α-glucopyranosyl sugar compound, and 2-O-α-D-glycosyl-L-ascorbic acid (n = 1 to 7) is mixed. A solution is obtained, and then β-amylase is allowed to act on the mixed solution to cleave the sugar chain having n = 4 or more, and 2-O-α-D-glycosyl-L-ascorbic acid (n = 1-3). Make a containing solution.
(2) Purify the 2-O-α-D-glycosyl-L-ascorbic acid (n = 1-3) -containing solution by removing unreacted L-ascorbic acid and saccharides using an ion exchange resin or the like. do.
(3) The solvent is removed to obtain powdered 2-O-α-D-glycosyl-L-ascorbic acid (n = 1 to 3).
The content ratio of 2-O-α-D-maltosyl-L-ascorbic acid can be controlled by the conditions at the time of production in step (2).

<2-O-α-D-グリコシル-L-アスコルビン酸金属塩>
本発明の2-O-α-D-マルトシル-L-アスコルビン酸及び2-O-α-D-マルトシル-L-アスコルビン酸以外の2-O-α-D-グリコシル-L-アスコルビン酸は塩であってもよく、好ましくは金属塩であってよい。2-O-α-D-グリコシル-L-アスコルビン酸と、金属塩と、を反応させることで2-O-α-D-グリコシル-L-アスコルビン酸の金属塩を製造することができる。
2-O-α-D-グリコシル-L-アスコルビン酸の金属塩の金属イオンとしては、ナトリウムイオン、カリウムイオンのようなアルカリ金属;マグネシウムイオン、カルシウムイオンのような第2族元素の金属イオン;鉄イオン、銅イオンのような遷移金属イオン;及び亜鉛イオン、アルミニウムイオンなどのその他の金属イオンからなる群より選ばれる金属イオン又はその組み合わせであってよい。
2-O-α-D-グリコシル-L-アスコルビン酸と反応させる金属塩としては、水酸化マグネシウム、水酸化ナトリウム、水酸化カリウム、水酸化カルシウム、塩化マグネシウム、塩化ナトリウム、塩化カリウム、塩化カルシウム、硫酸マグネシウム、硫酸ナトリウム、硫酸カリウム、硝酸ナトリウム、炭酸ナトリウム、炭酸水素ナトリウム、炭酸カリウム、リン酸ナトリウムなどがあげられる。水酸化マグネシウム、水酸化ナトリウム、水酸化カリウム、水酸化カルシウムなどの水酸化金属塩は、反応による副生成物が水であるため、特に好ましい。
<2-O-α-D-glycosyl-L-ascorbic acid metal salt>
2-O-α-D-glycosyl-L-ascorbic acid other than 2-O-α-D-maltosyl-L-ascorbic acid and 2-O-α-D-maltosyl-L-ascorbic acid of the present invention is a salt. It may be, preferably a metal salt. By reacting 2-O-α-D-glycosyl-L-ascorbic acid with a metal salt, a metal salt of 2-O-α-D-glycosyl-L-ascorbic acid can be produced.
Metal ions of the metal salt of 2-O-α-D-glycosyl-L-ascorbic acid include alkali metals such as sodium ion and potassium ion; metal ions of group 2 elements such as magnesium ion and calcium ion; It may be a metal ion selected from the group consisting of transition metal ions such as iron ion and copper ion; and other metal ions such as zinc ion and aluminum ion, or a combination thereof.
Metal salts to react with 2-O-α-D-glycosyl-L-ascorbic acid include magnesium hydroxide, sodium hydroxide, potassium hydroxide, calcium hydroxide, magnesium chloride, sodium chloride, potassium chloride, calcium chloride, etc. Examples thereof include magnesium sulfate, sodium sulfate, potassium sulfate, sodium nitrate, sodium carbonate, sodium hydrogencarbonate, potassium carbonate and sodium phosphate. Metal hydroxide salts such as magnesium hydroxide, sodium hydroxide, potassium hydroxide and calcium hydroxide are particularly preferred because the by-product of the reaction is water.

<2-O-α-D-グリコシル-L-アスコルビン酸の粉末の製造方法>
溶媒に前記2-O-α-D-グリコシル-L-アスコルビン酸を溶解させた溶液を作製する工程と、前記溶液を噴霧乾燥することによって、2-O-α-D-グリコシル-L-アスコルビン酸を粉末にさせる工程と、を含む方法によって2-O-α-D-グリコシル-L-アスコルビン酸の粉末を製造することができる。
前記溶媒は2-O-α-D-グリコシル-L-アスコルビン酸が溶解するものであれば公知の溶媒を自由に用いることができるが、好ましくは水及び/又はアルコールであり、特に好ましくは水である。前記アルコールとしてはエタノールが好ましい。
前記噴霧乾燥は、例えば、スプレードライヤーを用いて行うことができる。噴霧乾燥は、スプレードライヤーの入口温度を140~180℃で行うことが好ましく挙げられる。
140℃よりも低温であると溶媒を十分に蒸発させることができない可能性があるため、乾燥粉末が得られない恐れがある。一方、180℃よりも高温であると工程中に2-O-α-D-グリコシル-L-アスコルビン酸が分解又は揮散してしまう恐れがある。また、スプレードライヤーの出口温度は50~100℃で行うことが好ましく挙げられる。
<Method for producing powder of 2-O-α-D-glycosyl-L-ascorbic acid>
By preparing a solution in which the 2-O-α-D-glycosyl-L-ascorbic acid is dissolved in a solvent and spray-drying the solution, 2-O-α-D-glycosyl-L-ascorbic acid is used. A powder of 2-O-α-D-glycosyl-L-ascorbic acid can be produced by a method including the step of powdering the acid.
As the solvent, a known solvent can be freely used as long as it dissolves 2-O-α-D-glycosyl-L-ascorbic acid, but it is preferably water and / or alcohol, and particularly preferably water. Is. Ethanol is preferable as the alcohol.
The spray drying can be performed using, for example, a spray dryer. The spray drying is preferably performed at the inlet temperature of the spray dryer of 140 to 180 ° C.
If the temperature is lower than 140 ° C., the solvent may not be sufficiently evaporated, so that a dry powder may not be obtained. On the other hand, if the temperature is higher than 180 ° C., 2-O-α-D-glycosyl-L-ascorbic acid may be decomposed or volatilized during the process. Further, it is preferable that the outlet temperature of the spray dryer is 50 to 100 ° C.

本発明の2-O-α-D-マルトシル-L-アスコルビン酸及びそれを含有する組成物は、界面活性及び保湿性に優れ、べたつきが低く、肌への濡れ性に優れる。
本発明の2-O-α-D-マルトシル-L-アスコルビン酸及びそれを含有する組成物は、単独で、又は他の成分と併用して、飲食品、皮膚外用剤などとして用いることができる。
皮膚外用剤とは、外皮に適用する組成物を意味し、例えば化粧品、医薬品、医薬部外品を含む。外皮は、毛髪及び爪を含む。
皮膚外用剤としては、使用目的、製剤特性及び使用形態に応じて、一般的に皮膚外用剤の調製に際して使用される公知の基剤や担体などを適宜選択し、適用することができる。
また、必要に応じて、他の成分、例えば、界面活性剤、皮膚吸収促進剤、酸化防止剤、補助剤、紫外線吸収剤、増粘剤、増量剤、安定剤、着色剤、着香剤、防腐剤、防カビ剤、などと併用することができる。
皮膚外用剤は、軟膏剤、クリーム剤、噴霧剤、ローション剤、粉剤、ゲル剤、ゾル剤、エアロゾル剤、パップ剤、テープ剤などの剤形として、使用目的及び使用形態など所望により適宜選択し、調製することができる。
本発明の皮膚外用剤においては、皮膚外用剤全体に対して0.001~50重量%、0.01~20重量%、好ましくは0.1重量%~10重量%の2-O-α-D-グリコシル-L-アスコルビン酸を含む。2-O-α-D-グリコシル-L-アスコルビン酸中の2-O-α-D-マルトシル-L-アスコルビン酸の割合は前記したものが好ましい。
The 2-O-α-D-maltosyl-L-ascorbic acid of the present invention and the composition containing the same are excellent in surface activity and moisturizing property, low stickiness, and excellent wettability to the skin.
The 2-O-α-D-maltosyl-L-ascorbic acid of the present invention and the composition containing it can be used alone or in combination with other components as foods and drinks, external preparations for skin and the like. ..
The external skin preparation means a composition applied to the outer skin, and includes, for example, cosmetics, pharmaceuticals, and quasi-drugs. The rind includes hair and nails.
As the external skin preparation, known bases and carriers generally used in the preparation of external preparations for skin can be appropriately selected and applied according to the purpose of use, the characteristics of the preparation and the form of use.
In addition, if necessary, other components such as surfactants, skin absorption promoters, antioxidants, auxiliaries, UV absorbers, thickeners, bulking agents, stabilizers, colorants, flavoring agents, etc. It can be used in combination with preservatives, fungicides, etc.
The external skin preparation is appropriately selected as a dosage form such as an ointment, a cream, a spray, a lotion, a powder, a gel, a sol, an aerosol, a pap, a tape, etc., depending on the purpose of use and the form of use. , Can be prepared.
In the external preparation for skin of the present invention, 2-O-α- of 0.001 to 50% by weight, 0.01 to 20% by weight, preferably 0.1% by weight to 10% by weight, based on the whole external preparation for skin. Contains D-glycosyl-L-ascorbic acid. The ratio of 2-O-α-D-maltosyl-L-ascorbic acid in 2-O-α-D-glycosyl-L-ascorbic acid is preferably as described above.

以下の例において、本発明をより詳しく説明するが、本発明はこれにより限定されるものではない。
本発明におけるその他の用語や概念は、当該分野において慣用的に使用される用語の意味に基づくものであり、本発明を実施するために使用する様々な技術は、特にその出典を明示した技術を除いては、公知の文献等に基づいて当業者であれば容易かつ確実に実施可能である。また、各種の分析などは、使用した分析機器又は試薬、キットの取り扱い説明書、カタログなどに記載の方法を準用して行った。
なお、本明細書中に引用した先行技術文献、特許公報及び特許出願明細書中の記載内容は、本発明の記載内容として参照されるものとする。
The present invention will be described in more detail in the following examples, but the present invention is not limited thereto.
Other terms and concepts in the present invention are based on the meanings of terms commonly used in the art, and the various techniques used to carry out the present invention are those of particular origin. Except for this, those skilled in the art can easily and surely carry out the procedure based on known documents and the like. In addition, various analyzes were performed by applying the methods described in the analytical instruments or reagents used, the instruction manuals for the kits, catalogs, and the like mutatis mutandis.
The contents of the prior art documents, patent gazettes and patent application specifications cited in the present specification shall be referred to as the description contents of the present invention.

(製造例1)2-O-α-D-グリコシル-L-アスコルビン酸を含有する粉末の作製(n=1~3)
(1)2-O-α-D-グリコシル-L-アスコルビン酸の合成
水1000gに液化澱粉125gとL-アスコルビン酸50gを加えて溶解させ、pHを5に調整した。これに、シクロマルトデキストリングルカノトランスフェラーゼ酵素製剤(Toruzyme3.0L、Novozymes社製)を20g加えて、50℃にて48時間反応させることで、2-O-α-D-グルコピラノシル-L-アスコルビン酸、2-O-α-D-マルトシル-L-アスコルビン酸、2-O-α-D-マルトトリオシル-L-アスコルビン酸、2-O-α-D-マルトテトラオシル-L-アスコルビン酸などの2-O-α-D-グリコシル-L-アスコルビン酸を含有する反応液を得た。
得られた反応液を加熱することで酵素失活させて反応を停止させた後、β-アミラーゼ酵素製剤(β-アミラーゼ F「アマノ」、天野エンザイム(株)製)を0.7g加えて、50℃にて2時間反応させることで、2-O-α-D-グルコピラノシル-L-アスコルビン酸、2-O-α-D-マルトシル-L-アスコルビン酸、2-O-α-D-マルトトリオシル-L-アスコルビン酸を含む反応液を得た。反応後、加熱することで酵素を失活させて反応を停止させた。
(2)2-O-α-D-グリコシル-L-アスコルビン酸の精製
得られた反応液に活性炭を加えて脱色、ろ過した。ろ液を、H型カチオン交換樹脂を充填したカラムに通液して金属イオンを取り除いた後、OH型アニオン交換樹脂を充填したカラムに通液して2-O-α-D-グルコピラノシル-L-アスコルビン酸、2-O-α-D-マルトシル-L-アスコルビン酸、2-O-α-D-マルトトリオシル-L-アスコルビン酸を吸着させた。吸着したアニオン交換樹脂を水洗して未反応の糖類を除去した後、0.1Nの水酸化ナトリウムを通液することで、2-O-α-D-グルコピラノシル-L-アスコルビン酸、2-O-α-D-マルトシル-L-アスコルビン酸、2-O-α-D-マルトトリオシル-L-アスコルビン酸、それぞれを分離させて溶出させた。この時、2-O-α-D-マルトシル-L-アスコルビン酸を高純度で含有する分画を回収し、回収分画を変えることで、下記の表1に示す各組成の精製液を得た。
(Production Example 1) Preparation of powder containing 2-O-α-D-glycosyl-L-ascorbic acid (n = 1 to 3)
(1) Synthesis of 2-O-α-D-glycosyl-L-ascorbic acid 125 g of liquefied starch and 50 g of L-ascorbic acid were added to 1000 g of water and dissolved to adjust the pH to 5. To this, 20 g of a cyclomaltodexstring lucanotransferase enzyme preparation (Toruzyme 3.0L, manufactured by Novozimes) was added and reacted at 50 ° C. for 48 hours to cause 2-O-α-D-glucopyranocil-L-ascorbic acid. , 2-O-α-D-maltosyl-L-ascorbic acid, 2-O-α-D-maltotriosyl-L-ascorbic acid, 2-O-α-D-maltotetraosyl-L-ascorbic acid A reaction solution containing 2-O-α-D-glycosyl-L-ascorbic acid such as 2-O-α-D-glycosyl-L-ascorbic acid was obtained.
After inactivating the enzyme by heating the obtained reaction solution to stop the reaction, 0.7 g of β-amylase enzyme preparation (β-amylase F "Amano", manufactured by Amano Enzyme Co., Ltd.) was added. By reacting at 50 ° C. for 2 hours, 2-O-α-D-glucopyranosyl-L-ascorbic acid, 2-O-α-D-maltosyl-L-ascorbic acid, 2-O-α-D-malt A reaction solution containing triosyl-L-ascorbic acid was obtained. After the reaction, the enzyme was inactivated by heating to stop the reaction.
(2) Purification of 2-O-α-D-glycosyl-L-ascorbic acid Activated carbon was added to the obtained reaction solution for decolorization and filtration. The filtrate is passed through a column packed with an H-type cation exchange resin to remove metal ions, and then passed through a column filled with an OH-type anion exchange resin to pass 2-O-α-D-glucopyranosyl-L. -Ascorbic acid, 2-O-α-D-maltosyl-L-ascorbic acid, 2-O-α-D-maltotriosyl-L-ascorbic acid were adsorbed. The adsorbed anion exchange resin was washed with water to remove unreacted saccharides, and then 0.1N sodium hydroxide was passed through to pass 2-O-α-D-glucopyranosyl-L-ascorbic acid, 2-O. -Α-D-maltosyl-L-ascorbic acid and 2-O-α-D-maltotriosyl-L-ascorbic acid were separated and eluted. At this time, a fraction containing 2-O-α-D-maltosyl-L-ascorbic acid with high purity is recovered, and the recovered fraction is changed to obtain a purified liquid having each composition shown in Table 1 below. rice field.

Figure 0007018693000006
Figure 0007018693000006

Figure 0007018693000007
Figure 0007018693000007

(表中の数値の単位はモル%である)
さらに、各精製液を、H型カチオン交換樹脂を充填したカラムに通液することで、金属イオンを除去した2-O-α-D-グリコシル-L-アスコルビン酸を含有する組成物の精製液を得た。
(3)2-O-α-D-グリコシル-L-アスコルビン酸の噴霧乾燥
2-O-α-D-グリコシル-L-アスコルビン酸を含有した各水溶液を固形分15%程度まで加熱減圧濃縮した後、活性炭を加えて脱色精製を行い、ろ過した。ろ液をスプレードライヤー(日本ビュッヒ社製、B-290)にて入口温度160℃、出口温度75℃で噴霧乾燥を行うことで、2-O-α-D-グリコシル-L-アスコルビン酸を含有する組成物の粉末を得た。
(The unit of the numerical value in the table is mol%)
Further, the purified liquid of the composition containing 2-O-α-D-glycosyl-L-ascorbic acid from which metal ions have been removed by passing each purified liquid through a column filled with an H-type cation exchange resin. Got
(3) Spray drying of 2-O-α-D-glycosyl-L-ascorbic acid Each aqueous solution containing 2-O-α-D-glycosyl-L-ascorbic acid was heated and concentrated under reduced pressure to a solid content of about 15%. After that, activated carbon was added to perform decolorization and purification, and the mixture was filtered. The filtrate is spray-dried with a spray dryer (B-290, manufactured by Nippon Buch) at an inlet temperature of 160 ° C and an outlet temperature of 75 ° C to contain 2-O-α-D-glycosyl-L-ascorbic acid. The powder of the composition to be used was obtained.

(製造例2)2-O-α-D-グリコシル-L-アスコルビン酸を含有する粉末の作製(n=1~7)
(1)2-O-α-D-グリコシル-L-アスコルビン酸の合成
水1000gに液化澱粉125gとL-アスコルビン酸50gを加えて溶解させ、pHを5に調整した。これに、シクロマルトデキストリングルカノトランスフェラーゼ酵素製剤(Toruzyme3.0L、Novozymes社製)を20g加えて、50℃にて48時間反応させることで、2-O-α-D-グルコピラノシル-L-アスコルビン酸、2-O-α-D-マルトシル-L-アスコルビン酸、2-O-α-D-マルトトリオシル-L-アスコルビン酸、2-O-α-D-マルトテトラオシル-L-アスコルビン酸、2-O-α-D-マルトペンタオシル-L-アスコルビン酸、2-O-α-D-マルトヘキサオシル-L-アスコルビン酸、2-O-α-D-マルトヘプタオシル-L-アスコルビン酸などの2-O-α-D-グリコシル-L-アスコルビン酸を含有する反応液を得た。
反応後、加熱することで酵素を失活させて反応を停止させた。
(2)2-O-α-D-グリコシル-L-アスコルビン酸の精製
得られた反応液に活性炭を加えて脱色、ろ過した。ろ液を、H型カチオン交換樹脂を充填したカラムに通液して金属イオンを取り除いた後、OH型アニオン交換樹脂を充填したカラムに通液して2-O-α-D-グリコシル-L-アスコルビン酸を吸着させた。吸着したアニオン交換樹脂を水洗して未反応の糖類を除去した後、0.1Nの水酸化ナトリウムを通液することで、2-O-α-D-グリコシル-L-アスコルビン酸を溶出させた。
得られた2-O-α-D-グリコシル-L-アスコルビン酸の精製液の各組成比を下記表2に示す。
(Production Example 2) Preparation of powder containing 2-O-α-D-glycosyl-L-ascorbic acid (n = 1 to 7)
(1) Synthesis of 2-O-α-D-glycosyl-L-ascorbic acid 125 g of liquefied starch and 50 g of L-ascorbic acid were added to 1000 g of water and dissolved to adjust the pH to 5. To this, 20 g of a cyclomaltodexstring lucanotransferase enzyme preparation (Toruzyme 3.0L, manufactured by Novozimes) was added and reacted at 50 ° C. for 48 hours to cause 2-O-α-D-glucopyranosyl-L-ascorbic acid. , 2-O-α-D-maltosyl-L-ascorbic acid, 2-O-α-D-maltotriosyl-L-ascorbic acid, 2-O-α-D-maltotetraosyl-L-ascorbic acid , 2-O-α-D-maltopentaosyl-L-ascorbic acid, 2-O-α-D-maltohexaosyl-L-ascorbic acid, 2-O-α-D-maltoheptaosyl- A reaction solution containing 2-O-α-D-glycosyl-L-ascorbic acid such as L-ascorbic acid was obtained.
After the reaction, the enzyme was inactivated by heating to stop the reaction.
(2) Purification of 2-O-α-D-glycosyl-L-ascorbic acid Activated carbon was added to the obtained reaction solution for decolorization and filtration. The filtrate is passed through a column packed with an H-type cation exchange resin to remove metal ions, and then passed through a column filled with an OH-type anion exchange resin to pass 2-O-α-D-glycosyl-L. -Ascorbic acid was adsorbed. After washing the adsorbed anion exchange resin with water to remove unreacted sugars, 2-O-α-D-glycosyl-L-ascorbic acid was eluted by passing 0.1 N sodium hydroxide through the solution. ..
The composition ratios of the obtained purified liquids of 2-O-α-D-glycosyl-L-ascorbic acid are shown in Table 2 below.

Figure 0007018693000008
Figure 0007018693000008

(表中の数値の単位はモル%である)
さらに、精製液を、H型カチオン交換樹脂を充填したカラムに通液することで、金属イオンを除去した2-O-α-D-グリコシル-L-アスコルビン酸の精製液を得た。
(3)2-O-α-D-グリコシル-L-アスコルビン酸の噴霧乾燥
2-O-α-D-グリコシル-L-アスコルビン酸の水溶液を固形分15%程度まで加熱減圧濃縮した後、活性炭を加えて脱色精製を行い、ろ過した。ろ液をスプレードライヤー(日本ビュッヒ社製、B-290)にて入口温度160℃、出口温度75℃で噴霧乾燥を行うことで、2-O-α-D-グリコシル-L-アスコルビン酸の粉末を得た。
(The unit of the numerical value in the table is mol%)
Further, the purified liquid was passed through a column packed with an H-type cation exchange resin to obtain a purified liquid of 2-O-α-D-glycosyl-L-ascorbic acid from which metal ions had been removed.
(3) Spray drying of 2-O-α-D-glycosyl-L-ascorbic acid An aqueous solution of 2-O-α-D-glycosyl-L-ascorbic acid is heated and concentrated under reduced pressure to a solid content of about 15%, and then activated carbon is activated carbon. Was added to perform decolorization and purification, and the mixture was filtered. The filtrate is spray-dried with a spray dryer (B-290, manufactured by Nippon Buch) at an inlet temperature of 160 ° C and an outlet temperature of 75 ° C to form a powder of 2-O-α-D-glycosyl-L-ascorbic acid. Got

(製造例3)2-O-α-D-グリコシル-L-アスコルビン酸カリウム塩及びその粉末の作製
(1)前記した組成1の2-O-α-D-グリコシル-L-アスコルビン酸に対して、1モル当量の水酸化カリウムを加えて、40℃にて1時間撹拌することで、2-O-α-D-グリコシル-L-アスコルビン酸カリウム塩の水溶液を得た。
(2)2-O-α-D-グリコシル-L-アスコルビン酸カリウム塩の水溶液を固形分15%程度まで加熱減圧濃縮した後、活性炭を加えて脱色精製を行い、ろ過した。ろ液をスプレードライヤー(日本ビュッヒ社製、B-290)にて入口温度160℃、出口温度75℃で噴霧乾燥を行うことで、2-O-α-D-グリコシル-L-アスコルビン酸カリウム塩の粉末(組成1K塩)を得た。
前記した組成2~7の2-O-α-D-グリコシル-L-アスコルビン酸についても組成1と同様にして、2-O-α-D-グリコシル-L-アスコルビン酸カリウム塩の粉末(組成2~7K塩)を得た。
(Production Example 3) Preparation of 2-O-α-D-glycosyl-L-ascorbic acid potassium salt and powder thereof (1) With respect to 2-O-α-D-glycosyl-L-ascorbic acid of composition 1 described above. Then, 1 mol equivalent of potassium hydroxide was added, and the mixture was stirred at 40 ° C. for 1 hour to obtain an aqueous solution of 2-O-α-D-glycosyl-L-potassium ascorbic acid.
(2) An aqueous solution of 2-O-α-D-glycosyl-L-potassium ascorbic acid was concentrated under reduced pressure by heating to a solid content of about 15%, activated carbon was added, decolorization and purification were performed, and the mixture was filtered. The filtrate is spray-dried with a spray dryer (B-290, manufactured by Nippon Buch) at an inlet temperature of 160 ° C and an outlet temperature of 75 ° C to carry out 2-O-α-D-glycosyl-L-potassium ascorbate salt. Powder (composition 1K salt) was obtained.
Regarding 2-O-α-D-glycosyl-L-ascorbic acid of compositions 2 to 7 described above, the powder of 2-O-α-D-glycosyl-L-ascorbic acid potassium salt (composition) is the same as that of composition 1. 2-7K salt) was obtained.

(製造例4)2-O-α-D-グリコシル-L-アスコルビン酸ナトリウム塩及びその粉末の作製
1モル当量の水酸化カリウムに代えて、1モル当量の水酸化ナトリウムを用いた以外は製造例3と同様にして、2-O-α-D-グリコシル-L-アスコルビン酸ナトリウム塩の粉末(組成1~8Na塩)を得た。
(Production Example 4) Preparation of 2-O-α-D-glycosyl-L-ascorbate sodium salt and its powder Production except that 1 molar equivalent of sodium hydroxide was used instead of 1 molar equivalent of potassium hydroxide. In the same manner as in Example 3, a powder of 2-O-α-D-glycosyl-L-sodium ascorbate salt (composition 1-8Na salt) was obtained.

(製造例5)2-O-α-D-グリコシル-L-アスコルビン酸マグネシウム塩及びその粉末の作製
1モル当量の水酸化カリウムに代えて、0.5モル当量の水酸化マグネシウム塩を用いた以外は製造例3と同様にして、2-O-α-D-グリコシル-L-アスコルビン酸マグネシウム塩の粉末(組成1~8Mg塩)を得た。
(Production Example 5) Preparation of 2-O-α-D-glycosium-L-ascorbic acid magnesium salt and its powder A 0.5 molar equivalent of magnesium hydroxide was used instead of 1 molar equivalent of potassium hydroxide. A powder of 2-O-α-D-glycosyl-L-magnesium ascorbic acid salt (composition 1 to 8 Mg salt) was obtained in the same manner as in Production Example 3 except for the above.

(比較例)
比較例として、組成9:2-O-α-D-グルコピラノシル-L-アスコルビン酸、組成9K塩:2-O-α-D-グルコピラノシル-L-アスコルビン酸カリウム塩、組成9Na塩:2-O-α-D-グルコピラノシル-L-アスコルビン酸ナトリウム塩、組成9Mg塩:2-O-α-D-グルコピラノシル-L-アスコルビン酸マグネシウム塩、及び組成10:L-アスコルビン酸を用意した。
(Comparative example)
As a comparative example, composition 9: 2-O-α-D-glucopyranosyl-L-ascorbic acid, composition 9K salt: 2-O-α-D-glucopyranosyl-L-ascorbic acid potassium salt, composition 9Na salt: 2-O. -Α-D-Glucopyranocil-L-ascorbic acid sodium salt, composition 9Mg salt: 2-O-α-D-glucopyranocil-L-ascorbic acid magnesium salt, and composition 10: L-ascorbic acid were prepared.

<保湿性の評価>
組成1~10の各組成物及びその金属塩の10%水溶液20gを入れた、容量50mlのガラス瓶を、温度25℃、湿度35%のデシケーターに入れ、その時間当たり面積当たりの減少重量から保湿性を評価した。
<官能評価>
各組成物の10%水溶液を調製し、20~40歳の男性5名および女性5名の合計10名の被験者の前腕部に塗布し、塗布後30分間経過したときに、皮膚に対する保湿性を以下の評価基準に基づいて被験者に評価してもらい、その得点を合計した後、合計点を人数の10で除することにより、平均点を求めた。
評価基準
2点:塗布前よりも肌がしっとりする。
1点:塗布前よりも肌がややしっとりする。
0点:塗布前と変わらない。
<Evaluation of moisturizing property>
A glass bottle having a capacity of 50 ml containing 20 g of a 10% aqueous solution of each composition of compositions 1 to 10 and a metal salt thereof was placed in a desiccator having a temperature of 25 ° C. and a humidity of 35%. Was evaluated.
<Sensory evaluation>
A 10% aqueous solution of each composition was prepared and applied to the forearms of a total of 10 subjects, 5 males and 5 females aged 20 to 40 years, and 30 minutes after application, the skin was moisturized. The subjects were evaluated based on the following evaluation criteria, the scores were totaled, and then the total score was divided by 10 of the number of people to obtain the average score.
Evaluation criteria 2 points: The skin is moisturized than before application.
1 point: The skin is slightly moisturized than before application.
0 points: Same as before application.

その結果を下記の表3に示す。 The results are shown in Table 3 below.

Figure 0007018693000009
Figure 0007018693000009

Figure 0007018693000010
Figure 0007018693000010

Figure 0007018693000011
Figure 0007018693000011

Figure 0007018693000012
Figure 0007018693000012

Figure 0007018693000013
Figure 0007018693000013

Figure 0007018693000014
Figure 0007018693000014

Figure 0007018693000015
Figure 0007018693000015

Figure 0007018693000016
Figure 0007018693000016

(表中、保湿性の単位はmg/cm・hrである)
保湿性の試験の結果、2-O-α-D-マルトシル-L-アスコルビン酸を含有する組成物又はその塩(組成1~8又はその塩)は2-O-α-D-グルコピラノシル-L-アスコルビン酸のみの場合(組成9又はその塩)に比べて高い保湿性を有し肌の濡れ性に優れることが明らかになった。また、意外にも、n=4以上の糖鎖を含む組成物8又はその塩は保湿性に劣ることが分かった。n=2の2-O-α-D-マルトシル-L-アスコルビン酸又はその塩は、n=1やn=4以上の化合物よりも保湿性及び肌の濡れ性に優れていることが分かった。
(In the table, the unit of moisturizing property is mg / cm 2 · hr)
As a result of the moisturizing test, the composition containing 2-O-α-D-maltosyl-L-ascorbic acid or a salt thereof (compositions 1 to 8 or a salt thereof) is 2-O-α-D-glucopyranocil-L. -It was clarified that the ascorbic acid alone has a higher moisturizing property and an excellent wettability of the skin as compared with the case of only ascorbic acid (composition 9 or a salt thereof). Surprisingly, it was found that the composition 8 or a salt thereof containing a sugar chain having n = 4 or more is inferior in moisturizing property. It was found that 2-O-α-D-maltosyl-L-ascorbic acid with n = 2 or a salt thereof is superior in moisturizing property and skin wettability to compounds having n = 1 or n = 4 or more. ..

本発明は、保湿性が高く、べたつきがなく肌の濡れ性に優れた2-O-α-D-マルトシル-L-アスコルビン酸及びそれを含有する組成物を提供する。本発明の2-O-α-D-マルトシル-L-アスコルビン酸は化粧品などの皮膚外用剤として特に有用である。 The present invention provides 2-O-α-D-maltosyl-L-ascorbic acid, which has high moisturizing properties, is not sticky, and has excellent skin wettability, and a composition containing the same. The 2-O-α-D-maltosyl-L-ascorbic acid of the present invention is particularly useful as a skin external preparation for cosmetics and the like.

Claims (5)

下記一般式(1):
Figure 0007018693000017
(式中、nは1以上の整数を示す。)
で表わされる2-O-α-D-グリコシル-L-アスコルビン酸又はその塩を含有する組成物であって、前記2-O-α-D-グリコシル-L-アスコルビン酸中の70モル%以上が2-O-α-D-マルトシル-L-アスコルビン酸(n=2)である2-O-α-D-マルトシル-L-アスコルビン酸含有組成物、を含有することを特徴とする皮膚外用剤。
The following general formula (1):
Figure 0007018693000017
(In the formula, n indicates an integer of 1 or more.)
A composition containing 2-O-α-D-glycosyl-L-ascorbic acid or a salt thereof, which is represented by 70 mol% or more of the 2-O-α-D-glycosyl-L-ascorbic acid. For external use on the skin, which comprises 2-O-α-D-maltosyl-L-ascorbic acid-containing composition, which is 2-O-α-D-maltosyl-L-ascorbic acid (n = 2). Agent.
前記2-O-α-D-グリコシル-L-アスコルビン酸中の90モル%以上が2-O-α-D-マルトシル-L-アスコルビン酸(n=2)であることを特徴とする、請求項1に記載の皮膚外用剤。 Claimed that 90 mol% or more of the 2-O-α-D-glycosyl-L-ascorbic acid is 2-O-α-D- maltosyl -L-ascorbic acid (n = 2). Item 1. The external skin preparation according to Item 1. 前記2-O-α-D-グリコシル-L-アスコルビン酸中の、n=4以上の2-O-α-D-グリコシル-L-アスコルビン酸の割合が1モル%以下であることを特徴とする、請求項1又は2に記載の皮膚外用剤。 The proportion of 2-O-α-D-glycosyl-L-ascorbic acid having n = 4 or more in the 2-O-α-D-glycosyl-L-ascorbic acid is 1 mol% or less. The external skin preparation according to claim 1 or 2. 前記2-O-α-D-マルトシル-L-アスコルビン酸含有組成物が粉末であることを特徴とする、請求項1から3のいずれか一項に記載の皮膚外用剤。 The external skin preparation according to any one of claims 1 to 3, wherein the 2-O-α-D-maltosyl-L-ascorbic acid-containing composition is a powder. (a)下記一般式(1)
Figure 0007018693000018
(式中、nは1以上の整数を示す。)
で表わされる2-O-α-D-グリコシル-L-アスコルビン酸であって、n=1~7の2-O-α-D-グリコシル-L-アスコルビン酸を全て含む混合物を用意する工程と、
(b)前記混合物にβ-アミラーゼを作用させる工程と、
(c)β-アミラーゼを作用させた前記混合物を精製して2-O-α-D-マルトシル-L-アスコルビン酸含有組成物を得る工程
を有することを特徴とする、2-O-α-D-マルトシル-L-アスコルビン酸含有組成物の製造方法。

(A) The following general formula (1)
Figure 0007018693000018
(In the formula, n indicates an integer of 1 or more.)
A step of preparing a mixture of 2-O-α-D-glycosyl-L-ascorbic acid represented by 2 and containing all of 2-O-α-D-glycosyl-L-ascorbic acid having n = 1 to 7. ,
(B) A step of allowing β-amylase to act on the mixture, and
(C) 2-O-α-, which comprises a step of purifying the mixture on which β-amylase is allowed to act to obtain a 2-O-α-D-maltosyl-L-ascorbic acid-containing composition. A method for producing a D-maltosyl-L-ascorbic acid-containing composition.

JP2018554258A 2016-11-30 2017-11-30 2-O-α-D-maltosyl-L-ascorbic acid-containing composition and method for producing the same Active JP7018693B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2016233629 2016-11-30
JP2016233629 2016-11-30
PCT/JP2017/043137 WO2018101431A1 (en) 2016-11-30 2017-11-30 2-O-α-D-MALTOSYL-L-ASCORBIC ACID-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME

Publications (2)

Publication Number Publication Date
JPWO2018101431A1 JPWO2018101431A1 (en) 2020-01-16
JP7018693B2 true JP7018693B2 (en) 2022-02-14

Family

ID=62241720

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018554258A Active JP7018693B2 (en) 2016-11-30 2017-11-30 2-O-α-D-maltosyl-L-ascorbic acid-containing composition and method for producing the same

Country Status (3)

Country Link
JP (1) JP7018693B2 (en)
TW (1) TW201827038A (en)
WO (1) WO2018101431A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030024934A (en) 2001-08-23 2003-03-28 박관화 Ascorbic acid derivatives with antioxidnat activity and high stability and preparation method for the same
JP2010539105A (en) 2007-09-14 2010-12-16 南京中▲獅▼▲化▼学品有限公司 Ascorbic acid derivative, process for producing the same and use of such intermediates and derivatives thereof in cosmetics
WO2015046848A1 (en) 2013-09-27 2015-04-02 고려대학교 산학협력단 Cyclodextrin glucanotransferase mutant enzyme and method for producing l-ascorbic acid using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3134236B2 (en) * 1992-01-30 2001-02-13 株式会社林原生物化学研究所 Method for producing high α-glycosyl-L-ascorbic acid content and separation system for the production
JPH06211636A (en) * 1993-01-13 1994-08-02 Lion Corp Oral composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030024934A (en) 2001-08-23 2003-03-28 박관화 Ascorbic acid derivatives with antioxidnat activity and high stability and preparation method for the same
JP2010539105A (en) 2007-09-14 2010-12-16 南京中▲獅▼▲化▼学品有限公司 Ascorbic acid derivative, process for producing the same and use of such intermediates and derivatives thereof in cosmetics
WO2015046848A1 (en) 2013-09-27 2015-04-02 고려대학교 산학협력단 Cyclodextrin glucanotransferase mutant enzyme and method for producing l-ascorbic acid using same

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Agricultural and Biological Chemistry,1991年,Vol. 55, No. 7,p. 1751-1756
Applied Biochemistry and Microbiology,2007年,Vol. 43, No. 1,p. 36-40
Bioscience, Biotechnology, and Biochemistry,2004年,Vol. 68, No. 1,p. 36-43
Food Chemistry,2015年,Vol. 169,p. 366-371
Journal of Agricultural and Food Chemistry,2002年,Vol. 50,p. 3309-3316

Also Published As

Publication number Publication date
JPWO2018101431A1 (en) 2020-01-16
WO2018101431A1 (en) 2018-06-07
TW201827038A (en) 2018-08-01

Similar Documents

Publication Publication Date Title
JPS60178887A (en) Preparation of 5,6,7,8-tetrahydro-l-biopterin
CN107163160A (en) A kind of Ascorbic acid chitosan quaternary ammonium salt and its preparation method and application
HU184626B (en) Congesting cosmetics first of all hair-restorers
JP3772468B2 (en) L-ascorbic acid-2-phosphate zinc salt and method for producing the same
JP7018693B2 (en) 2-O-α-D-maltosyl-L-ascorbic acid-containing composition and method for producing the same
JP2021529243A5 (en)
CN109096129A (en) A kind of preparation method of L-carnitine-L-tartrate
JP6895436B2 (en) 2-O-α-D-glycosyl-L-ascorbic acid metal salt, its use as an antioxidant and its powder production method
CN101787038B (en) Preparation method of cefquinome sulfate
US2710860A (en) Nikethamide adenylate
JP6991142B2 (en) 6-Acyl-2-O-α-D-glycosyl-L-ascorbic acid, compositions containing it, and methods for producing them.
JP2001163720A (en) Moisturizing agent, skin cosmetic and preparation for external use for skin
US2042019A (en) Process of preparing the reaction product of hydrated aluminum oxide and gluconic acid
JPS58101660A (en) Improving method for solubility of steviolbioside
US3751564A (en) Process for preparing scleroprotein-alkyl thiosulfate agents for the care of the hair
CN108285470B (en) A method of synthesis L-Ascorbic Acid L-O-Phosphate
CN108503548B (en) Pyruvic acid menthyl ester cooling agent and preparation method thereof
JPS5934710B2 (en) Method for producing a molecular compound of allantoin and ornithine
FR2567130A1 (en) SUGAR PHOSPHATES FOR USE IN SHAMPOO, RINSE AND COSMETICS, AND PROCESS FOR PREPARING THESE PHOSPHATES
WO2020170840A1 (en) CRYSTAL OF POTASSIUM SALT OF 2-O-α-D-GLUCOSYL-L-ASCORBIC ACID AND PRODUCTION METHOD THEREFOR
JP2010030907A (en) Novel antioxidative compound, antioxidant comprising the same as its effective component, and method of preparing the same
JPS63218616A (en) Bathing agent
JPH08134090A (en) Galactosyl kojic acid, its production and tyrosinase-inhibiting agent containing the same
JP2023517911A (en) Personal care composition containing mannose oligosaccharides
JPS6357439B2 (en)

Legal Events

Date Code Title Description
AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20190809

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190902

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201009

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201009

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211004

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211013

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220131

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220131

R150 Certificate of patent or registration of utility model

Ref document number: 7018693

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250